NYSE: LHLaboratory Corporation of America Holdings

HealthcareMkt Cap $27.28BCongress ownership rank #391

Laboratory Corporation of America Holdings Congressional Trading

According to U.S. congressional financial disclosures filed under the STOCK Act, members of Congress have reported 67 trades in Laboratory Corporation of America Holdings (NYSE: LH) since 2014, across 17 members, worth an estimated $1.3M in disclosed volume (the midpoint of the dollar ranges members report, not exact amounts). 39 buys against 28 sells, a modestly buy-led skew, with Democratic members responsible for 57% of the trades and Republican members 43%. The most recent disclosure shown was filed July 2026, and Rohit Khanna has filed the most LH transactions among those shown, with 9. Other recent filers include Alan Armstrong, Tony Wied, and April McClain Delaney. One notable disclosed move was a purchase by April McClain Delaney on October 29, 2025, up 37.2% since. These figures are drawn from public House and Senate periodic transaction reports and reflect what members were required to disclose, not the current market value of any position. Laboratory Corporation of America Holdings's current Quantellect Tide Score is 77 out of 100 (High Tide), Top 10% of universe (3876); the Tide Score is generated algorithmically from public filings and market data and is not investment advice. For the full record, including the month-by-month buy and sell timeline, the party breakdown, top buyers and sellers, and every individual filing, see the Laboratory Corporation of America Holdings (LH) stock overview and the complete trade table below.